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a b s t r a c t
The glucocorticoid receptor (GR) signal transduction and transcriptional regulation are efﬁciently reca-
pitulated when GR is expressed in Saccharomyces cerevisiae. In this report we demonstrate that the in
vivo GR phosphorylation pattern, hormone dependency and interdependency of phosphorylation events
were similar in yeast and mammalian cells. GR phosphorylation at S246 exhibited inhibitory effect on
S224 and S232 phosphorylation, suggesting the conservation of molecular mechanisms that control this
interdependence between yeast and mammalian cells.
To assess the effects of GR phosphorylation the mutated GR derivatives T171A, S224A, S232A, S246A
were overexpressed and their transcriptional activity was analysed. These receptor derivatives displayed
signiﬁcant hormone inducible transcription when overexpressed in S. cerevisiae. We have established aneast inducible methionine expression system, which allows the close regulation of the receptor protein levels
to analyse the dependence of GR function on its phosphorylation and protein abundance. Using this sys-
tem we observed that GR S246A mutation increased its activity across all of the GR concentrations tested.
The activity of the S224A and S246A mutants was mostly independent of GR protein levels, whereas the
WT, T171A and S232A mediated transcription diminished with declining GR protein levels. Our results
suggest that GR phosphorylation at speciﬁc residues affects its transcriptional functions in a site selective
were
Cromanner and these effects
. Introduction
Glucocorticoid receptor (GR) is a member of the nuclear hor-
one receptor superfamily of transcription factors. GR is the
ntracellular, ligand-regulated transcription factor that plays an
mportant role in numerous cellular processes and responses to
xtracellular signals [1]. GR is ubiquitously expressed in mam-
alian cells and in the absence of ligand is complexed with
haperones suchasheat shockprotein90.Oncebound to the ligand,
R is activated, dissociates from chaperones and translocates into
he nucleus, where it binds to glucocorticoid responsive elements
∗ Corresponding author at: Faculty of Life Sciences, Michael Smith Building,
niversity ofManchester, OxfordRoad,Manchester,M139PT, England,UnitedKing-
om. Tel.: +44 161 275 1501; fax: +44 161 275 5082.
E-mail address: m.k.demonacos@manchester.ac.uk (M. Krstic-Demonacos).
1 Deceased.
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Open access under CC BY licensedirectly linked to GR dosage.
wn Copyright © 2010 Published by Elsevier Inc. 
(GREs) and activates or represses the transcription of numerous
target genes depending on cell type, promoter context and physio-
logical settings [1]. Multiple factors such as interaction with the
chaperone complexes, binding afﬁnity and type of GREs, intra-
cellular trafﬁcking, interaction with numerous co-activators and
co-repressors and covalent modiﬁcations determine GR transcrip-
tional activity [1–3].
One of the most important and extensively studied post-
translational modiﬁcations of GR is phosphorylation. Seven
phosphorylation sites have been identiﬁed in GR isolated from
mouse and hamster cells [4]. Glucocorticoid receptor expressed in
yeast (Saccharomyces cerevisiae) is phosphorylated at T171, S224,
S232, andS246 [5].GRphosphorylationat these sites locatedwithin
Open access under CC BY license.the N-terminal transactivation domain was reported to regulate
various functional properties of this transcription factor [6,7]. For
example, phosphorylationwas suggested to control receptor stabil-
ity and nuclear localization and to facilitate GR sumoylation [8–10].
However, GR phosphorylation has been shown to exert stimu-
.
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atory and inhibitory effects on its transcriptional functions in a
arget gene speciﬁc manner [5,10,11]. The N-terminal transactiva-
ion domain of GR is a target for several signalling pathways and
inase cascades. Mitogen activated protein kinases (MAPKs) phos-
horylate the rat GR at T171 and S246, whereas cyclin dependent
rotein kinases (CDKs) phosphorylate S224 and S232 [5]. The T171
ite is targeted by glycogen synthase kinase-3 (GSK-3) dependent
hosphorylation [5,7]. The JNK subfamily of the MAP kinases phos-
horylates GR modifying most efﬁciently the S246 residue [10,12].
educed receptor-dependent transcriptional enhancement inyeast
trains deﬁcient in the catalytic or regulatory subunits of CDKs
as been reported. On the contrary, deletions of FUS3 and KSS1
AP kinase homologues in yeast increase GR mediated transcrip-
ion suggesting that GRphosphorylation by these kinasesmayhave
nhibitory effect on its function [5].
Although several studies have provided insight into the effects
f phosphorylation on GR function, numerous mechanistic details
f this control are still not known. It has previously been shown
hat GR phosphorylation pattern and transcriptional activity can
fﬁciently be recapitulated in yeast S. cerevisiae [5,13,14]. In yeast
ctopically expressing GR, phosphorylation occurs rapidly and is
bserved in both the absence and the presence of hormone treat-
ent. Phosphorylation of T171 and S246 occurred in both the
bsence and the presence of hormone and S224 and S232 phospho-
ylation increased after the addition of hormone to the yeastmedia.
R phosphorylation studies in mammalian cells have suggested
hat the modiﬁcation of one site affects phosphorylation and/or
ther post-translational modiﬁcations of residues in the vicinity.
or example, phosphorylation ofGR at S224 inhibits S246phospho-
ylation or vice versa,whereas the consequence of the JNKpathway
ctivation and hence S246 phosphorylation is the augmentation
f GR sumoylation [5,10,15]. Despite above mentioned and other
tudies [16,17] indicating the importance of phosphorylation for
he function of a plethora of transcription factors there are very few
eports describing effects of this modiﬁcation on protein–protein
ontacts for GR [18]. The complexity of receptor’s phosphorylation
nddifﬁcultyofmonitoring the relatively subtle effects of phospho-
ylation site mutations on protein function prompted us to explore
he possibility of developing a more tractable system to approach
his question. Given the similarity of the events mediated by the
hosphorylated GR in yeast with those taking place in mammalian
ells together with the simplicity and genetic manipulability of the
east we have chosen S. cerevisiae to study the phosphorylation
ependent GR activities and have established expression system
here GR protein concentration can be carefully regulated.
In the present report, based on the analysis of phosphopeptide
atterns of the wild type and mutant receptor, we verify that hor-
one dependency and interdependency of phosphorylation sites
bserved in mammalian cells is preserved in yeast. Furthermore,
e provide evidence that the effects of the receptor phosphoryla-
ion are residue speciﬁc and closely linked to the quantity of the
eceptor protein in the cell.
. Experimental
.1. Yeast and mammalian cells
The triple protease deﬁcient yeast S. cerevisiae strain, BJ2168 (a,
ep 4-3, prc 1–417, prb 5–1122, ura 3–52, trp 1, leu 2) [19] was
sed, and the expression and reporter vectors were introduced
s described below. Yeast cultures were propagated at 30 ◦C in
inimal yeast medium with amino acids and 2% glucose. Trans-
ormations were performed by the lithium acetate procedure [20].
RH2 rat hepatoma cells have integrated copies of the rat GR cDNA
nd express increased levels of the glucocorticoid receptor [21].75 (2010) 457–465
2.2. Plasmids
The yeast expression plasmid pG-N795 [13] carries the rat
glucocorticoid receptor [GR] cDNA expressed from the yeast
glyceraldehyde-3-phosphate dehydrogenase [GPD] promoter. This
plasmid is a 2 vector (10–40 copies per cell) with the TRP1
selectable marker. Reporter plasmid ps26x contains three tan-
dem 26bp oligonucleotides from the tyrosine aminotransferase,
URA3 selectable marker and has been described previously [5,22].
Expressionplasmidp414Met25has previously beendescribed [23]
and is a gift from M. Funk. The rat glucocorticoid receptor cDNA
WT, and mutant derivatives T171A, S224A, S232A and S246A were
obtained by isolating fragments carrying rat GR cDNA from the
PGN795 plasmid and inserting them into the BamH1 site of p414
MET25 vector. All constructs were conﬁrmed by restriction diges-
tion and sequencing.
2.3. Metabolic labeling and phosphopeptide mapping
Metabolic labeling and the phosphopeptide mapping exper-
iments were performed as described before [14]. Brieﬂy, the
yeast strain BJ2168 containing the GR expression vector pG-N795
was grown to O.D. 600nm 0.4–0.7 in 50ml of minimal selective
yeast medium with amino acids and 2% glucose. The cells were
washed once and incubated for 30min at 30 ◦C in 50ml phosphate-
free medium. The cells were labeled with (32P) orthophosphate
(25mCi/ml, carrier free, New England Nuclear, USA) to a ﬁnal
concentration of 1mCi/ml; one portion was brought to 10M
deoxycorticosterone (DOC) (Sigma, USA). After 2h at 30 ◦C, cells
were harvested by centrifugation, washed in 5ml of cold PBS and
resuspended in 350l of high salt lysis buffer (45mM HEPES pH
7.5, with 10% glycerol, 1mM Na2EDTA, 400mM NaCl, 2mM DTT,
0.5% NP40, 25mM sodium ﬂuoride, 20mM -glycerophosphate,
5mMsodiumpyrophosphate and a protease inhibitor cocktail con-
taining 1g/ml each of aprotinin, leupeptin and pepstatin A, and
1mM PMSF). An equal volume of acid washed glass beads was
added and cells were vortexed for 15min using a horizontal bead
beater (Eppendorf, USA). Cell lysateswere clearedby centrifugation
at 12,000× g for 10min at 4 ◦C. The supernatant was used for the
immunoprecipitation of the receptor and samples were analysed
by SDS-PAGE. Polyacrylamide gels containing the labeled recep-
tor were washed in water and dried between cellophane sheets.
Following autoradiography, the GR band was excised and gel was
rehydrated and eluted in 50mM ammonium acetate, 1mM DTT.
For digestion with V8 protease, the rehydrated gel slice was placed
into a microfuge tube at room temperature in 50mM ammonium
acetate, 1mM DTT and 50g/ml of V8 protease (Endoproteinase
Glu-C, Boehringer Mannheim), adjusted to pH 4 and incubated at
37 ◦C overnight. Samples were centrifuged for 5min at 12,000× g
and the supernatant containing the digested peptides was evapo-
rated to dryness in a Speedvac (Savant, Farmingdale, USA). Peptides
were resuspended in 500l of water, dried and washed once more.
Finally, peptides were dissolved in 10l of 15% acetic acid, 5%
formic acid. Sample containing >1000 cpm was used for 2-D phos-
phopeptides analysis. Peptides were electrophoresed in 15% acetic
acid, 5% formic acid on cellulose plates (microcrystalline cellulose
adsorbent without ﬂuorescent indicator; Kodak, USA) at 1000V for
50min. Plates were then dried and subjected to ascending chro-
matography in the second dimension for 3h with 37.5% butanol,
25% pyridine, 7.5% acetic acid, air dried and exposed to ﬁlm [24].2.4. Preparation of cell extracts, immunoprecipitation and
immunoblotting
The yeast strain BJ2168 containing theGR expression vector pG-
N795 and vector p414 MET25N795 were grown to O.D. 600nm
eroids
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.4–0.7 in 50ml minimal selective yeast medium with amino acids
nd 2% glucose. One portion was treated with 10M deoxycorti-
osterone (Sigma, USA) for 2h at 30 ◦C. The cells were harvested by
entrifugation, washed once in 5ml of cold PBS and resuspended
n 350l of high salt lysis buffer as described above. An equal
olume of acid washed glass beads was added and cells were vor-
exed for 15min using a horizontal bead beater (Eppendorf). Cell
ysates were cleared by centrifugation at 12,000× g for 10min at
◦C. The supernatant was placed in a fresh tube. To immunopre-
ipitate the GR, an equal volume of RIPA buffer (10mM HEPES pH
.5, 150mM NaCl, 0.1% Na2deoxycholate, 1% Triton X-100) was
dded to cleared cell lysates, together with 5ml of ascities ﬂuid
ontaining the rat GR speciﬁc monoclonal antibody BUGR2 [25].
fter 1–2h at 4 ◦C, 100l of 50mg/ml protein A–sepharose (Sigma,
SA) equilibrated in RIPA buffer was added and incubated for
dditional 2h with gentle agitation at 4 ◦C. Protein A–sepharose
as collected by centrifugation, washed 4 times with ice cold
IPA buffer, and once with PBS. Bound protein was released in
× SDS sample buffer (0.125M Tris pH 6.8, 20% glycerol, 4% SDS,
0% -mercaptoethanol and 0.004% bromophenol blue), displayed
n 7.5% SDS polyacrylamide gels and transferred to Immobilon-
membranes (Millipore, USA). Immunoblots were probed with
he indicated antibodies and developed with the enhanced chemi-
uminescence substrate according to manufacturer’s instructions
Pierce Chemical Co., Rockford, IL). Intensity of the bandswas quan-
iﬁed using Image J software.
.5. Synthetic peptides
Phosphopeptides were synthesized on HMP resin using stan-
ard HOBT active ester/FMOC chemistry on an ABI 431-A peptide
ynthesizer (Applied Biosystems). Residues to be phosphory-
ated were coupled as alcohol-unprotected FMOC derivatives
nd were phosphorylated after synthesis with di-t-butyl-N,N-
iisopropylphosphoramidite/tetrazole followed by the oxidation
f trivalent phosphorus with t-butylhydroperoxide. Peptides were
leaved and deprotected with Reagent K, puriﬁed by reversed-
hase HPLC and characterized by electrospray-ionization mass
pectrometry (Hewlett-Packard model 5989A). 50g of each pep-
ide was dissolved in 10l of electrophoresis buffer, loaded on TLC
lates and electrophoresis and chromatography were performed
s described above. Plates were dried and synthetic peptides were
isualized with ninhydrin. These peptides were used as markers to
dentify phosphopeptides labeled in vivo by co-migration.
.6. ˇ-Galactosidase assay in yeast
-Galactosidase activity was assayed as previously described
13]. Brieﬂy, yeast cells carrying indicated GR expression vectors
nd ps26x reporter vector were collected by centrifuga-
ion from 1.5ml of cultures and washed with Lac Z buffer
100mM sodium phosphate buffer pH 7.0, 10mM KCl, 1mM
gSO4 and 50mM -mercaptoethanol). After recentrifugation,
ells were resuspended in 50l of Lac Z buffer and per-
eabilized with 50l of chloroform and 20l of 0.1% SDS;
-galactosidase substrate (o-nitro-phenyl--galactoside, 0.7ml of
mg/ml) was added and the reaction was stopped with 0.5ml
f 1M Na2CO3 after 1–10min incubation. The -galactosidase
ctivity was assayed spectrophotometricaly by measuring O.D.
20nm. Results are presented as mean± SEM (n=6) obtained
rom six or more measurements. For establishing signiﬁcant
ifferences data were analysed by t-test and the values were
onsidered statistically signiﬁcant if the p value was less than
.05.75 (2010) 457–465 459
3. Results
3.1. GR phosphorylation sites and their hormone dependency is
similar in yeast and mammalian cells
Phosphopeptide mapping was performed to determine the
phosphorylation status of GR expressed in yeast and mammalian
cells. Hormone-treated yeast and rat hepatoma cells expressing
the receptorweremetabolically labeledwith (32P) orthophosphate,
and the receptorwas isolatedby immunoprecipitationanddigested
with V8 protease as previously described [5]. The resulting phos-
phopeptideswere separatedon thin-layerplates in twodimensions
by electrophoresis and chromatography, respectively [24]. Sepa-
rate labeling reactions were carried out on hormone-treated (Fig.
1B and D) and control cultures (Fig. 1A and C). The phosphopeptide
patterns of receptor labeled in yeast and mammalian cells were
strikingly similar,withﬁvemajorphosphopeptidesgeneratedupon
V8 cleavage (Fig. 1, compare panels A and B with panels C and D).
The extent of phosphorylation of these peptides seemed roughly
uniform between species, except for peptide 1, which appeared
more intense in yeast than in mammalian cells; in fact peptide 1
may represent a cluster of more than one peptide (Fig. 1; see also
Fig. 2) whose sites are phosphorylated at low relative stoichiome-
tries in the mammalian receptor.
3.2. Interdependence of GR phosphorylation sites is conserved in
yeast
Earlier reports have identiﬁed seven GR phosphorylated
residues in hormone-treated mouse cells, displaying different
GR phosphorylation efﬁciencies [4]. To investigate the GR phos-
phorylation state we mutated four predominant sites at the
corresponding rat receptor residues from serine or threonine to
alanine (T171A, S224A, S232A and S246A), and characterized these
derivatives inmetabolically labeledyeast.V8phosphopeptideanal-
ysis of thesepointmutants inhormone-treatedandcontrol cultures
is shown in Fig. 2. The absence of peptide 1 is evident in the
T171A mutant in both the absence and the presence of hormone
(Fig. 2A and E); the residual labeling at this position is possibly
due to one or more minor peptides co-migrating at that position.
In a similar manner, the S246A receptor lacked peptides 5a and
5b independently of hormone treatment (Fig. 2D and H). A sig-
niﬁcant increase in the intensity of the peptides 2 and 4 in this
mutant was detected potentially due to interdependency of phos-
phorylation sites. Notably the weakly phosphorylated peptide 3 in
these experiments was evidently detected after longer exposures
of all mutated derivatives apart from the S224A. The phosphopep-
tide pattern of the S224A mutant differed from that of the wild
type receptor since the peptide 3 was absent in non-treated cells,
and hormone treatment resulted in disappearance of both peptides
3 and 4 (Fig. 2B and F), whereas peptide 5a intensity was signiﬁ-
cantly increased. The S232A receptor derivative lacked the peptide
4, suggesting that S232 phosphorylation is stimulated by hormone
(Fig. 2C and G). The simplest interpretation of these ﬁndings is that
the peptide 4 carries hormone-dependent phosphorylation onboth
S224 and S232.
In fact, phosphotryptic peptide mapping of the mutant receptor
derivatives in both yeast and mammalian cells supports the notion
that T171 and S246 are phosphorylated constitutively, whereas the
phosphorylation of S224 and S232 increases upon the addition of
hormone [5,14]. Thus, each of the four receptor derivatives bearing
an Ala substitution in a putative phosphorylation site lacked one or
two phosphopeptides relative to the wild type receptor.
The alteration of twopeptides after themutation of oneputative
target residue might be a result of partial proteolysis, or interde-
pendence of one phosphorylation event upon another. To resolve
460 N. Popovic et al. / Steroids 75 (2010) 457–465
Fig. 1. V8 phosphopeptides of glucocorticoid receptor expressed in yeast and mammalian cells. Yeast (A and B) or mammalian (C and D) cells were incubated with (32P)
orthophosphate in thepresence (B andD) or absence (A andC) of 10Mdeoxycorticosterone (DOC) and0.1Mdexamethasone (DEX), respectively, receptorwas immunopre-
cipitated, resolved by SDS-PAGE, isolated from the gel and digested with V8 protease. Two-dimensional peptide mapping was performed by electrophoresis (ﬁrst dimension)
and chromatography (second dimension), and exposed to ﬁlm and yeast pattern was compared to the known phosphopeptide pattern from mammalian cells [5]. Arrow
identiﬁes peptide whose labeling is hormone dependent.
Fig. 2. Phosphopeptide mapping of the glucocorticoid receptor phosphorylation site point mutations. Receptor mutants T171A (panels A, E), S224A (panels B, F), S232A
(panels C, G) and S246A (panels D, H) were isolated from (32P) labeled yeast cells and cleaved with V8 proteases as described in Section 2. Phosphopeptide maps are shown
for cells incubated in the absence (panels A–D) and presence (panels E–H) of hormone. Arrows identify positions of labeled peptides present in wild type receptor and lacking
in mutant GR derivatives.
N. Popovic et al. / Steroids 75 (2010) 457–465 461
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east cells. The sequences of respective peptides are given below.
hese and other possibilities, we synthesized the predicted V8
hosphopeptides of the receptor (Fig. 3A), puriﬁed them, estab-
ished their identities by mass spectroscopy, and compared their
ositions on 2D peptide maps with those of the receptor phospho-
eptides observed after metabolic labeling. The results conﬁrmed
hat phosphopeptide 5a contains a phosphoserine at position 246
Fig. 3A), and that phosphopeptide 1 includes the phosphorylated
171 residue (Fig. 3C). The 2 and 3 peptides correspond to the
20–242 or 220–231 fragments, respectively, with a single phos-
horylation site at S232 or S224, whereas peptide 4 coincides with
he doubly phosphorylated version of this peptide (Fig. 3B). An
nterdependence of hormone-stimulated phosphorylation of thesevidual peptides (50g) or subsets of peptides were fractionated by electrophoresis
246; Panel B: peptides 2–4, fractionated together (in other experiments, they were
el D: receptor speciﬁc V8 phosphopeptides from in vivo labeled hormone-treated
two residues may account for the intensity of this phosphopeptide
and it is not due to different solubility of the peptides isolated in
vivo. Together, these experiments produced an internally consis-
tent interpretation of the speciﬁc residues phosphorylated in yeast
cells in vivo, and conﬁrmed their identiﬁcation obtained in vitro
(Figs. 1 and 3).3.3. Effects of phosphorylation site mutations on receptor
activity—constitutive overexpression system
We next assessed whether the mutation of any of the phospho-
rylation sites on the receptor affects its transcriptional regulatory
462 N. Popovic et al. / Steroids
Fig. 4. Effects of glucocorticoid receptor phosphorylation analysed in the constitu-
tive overexpression system. (A) Western blot analysis of the expression levels of the
WTandmutant GRderivatives expressed from the PG-1 plasmid. (B) Transcriptional
a
(
o
u
a
s
P
r
i
c
o
f
c
t
t
e
W
e
c
g
[
i
t
w
r
p
t
e
i
t
3
a
c
s
p
Tctivity of GR and its derivatives measured by-galactosidase assay in the presence
+) or absence (−) of hormone. Results are presented as mean± SEM (n=6) from six
r more independent measurements. Statistically signiﬁcant differences between
ntreated samples and samples treated with hormone are given as *p<0.05.
ctivities.We examined two expression systems in yeast cells: con-
titutive and regulated. Constitutive overexpression system uses
G1 plasmid carrying the cDNA for the wild type GR and phospho-
ylation site mutants (T171A, S224A, S232A and S246A) introduced
nto the yeast cells. The expression of the receptor was under the
ontrol of GPDH promoter that yields high and constitutive levels
f protein expression. In addition, PG1 plasmid is of 2 origin con-
erring a high copy of the glucocorticoid receptor (10–40 copies per
ell) and these factors in combination resulted in overexpression of
he glucocorticoid receptor using this method. The wild type and
heGRmutantswereexpressed inyeast andprotein expression lev-
ls assessed by western blot analysis of cellular extracts (Fig. 4A).
e observed that all GR derivatives were expressed at similar lev-
ls as compared to tubulin protein levels that served as the loading
ontrol.
The transcriptional activity of GR was analysed using a reporter
ene containing TAT3 derived GREs fused to -galactosidase cDNA
5]. Both wild type and mutant GR transcriptional activity was
nduced by hormone addition (Fig. 4B) and this induction was sta-
istically signiﬁcant in all GR derivatives studied. Although there
as a trend indicating impaired activity of the S224A and S232A
eceptor mutants and increased S246A receptor activity in the
resence of hormone as compared to the wild type GR (Fig. 4B),
hese differences were not statistically signiﬁcant. Therefore, these
ffects were modest and unsuitable for the genetic screening
ntending to isolate proteins that display differential binding pat-
erns depending on the GR phosphorylation status.
.4. Effects of phosphorylation site mutations on receptor
ctivity—regulable expression systemTo establish an experimental system where the expression and
ellular concentration of the GR can be rigorously controlled, we
ubcloned the cDNA of the wild type GR and GR carrying phos-
horylation site mutations cDNA into the p414 MET25 vector.
his vector is a pRS vector carrying methionine promoter and can75 (2010) 457–465
express one copyper cell,which is lower than the PG1vector driven
genes. The expression of genes driven by the p414MET25promoter
can be regulated by the amount of methionine in the media [23]. In
the absence of methionine, this promoter is expressed at the high-
est level whereas concentration dependent levels of GR protein can
be achieved by increasing methionine concentrations. The expres-
sionof theGRprotein in this systemshown inFig. 5AandB indicates
that the wild type and mutant receptors were expressed at similar
levels and that the GR protein levels decreased with the increas-
ing methionine concentrations. In the next series of experiments
we tested the effects of phosphorylation site mutations on the GR
transcriptional activity in thepresenceof increasing concentrations
of methionine.
The activity of the wild type receptor increased with hormone
addition and this increasewas statistically signiﬁcant up tomethio-
nine concentration of 50M (Fig. 5C, ﬁrst panel). At methionine
concentrations up to 100M the T171A and S232A GR mutants
exhibited hormone induced transcription whereas higher methio-
nine concentrations rendered these derivatives transcriptionally
inactive. In contrast, activity of S224A and S246A GR deriva-
tives was hormone dependent across all methionine concentration
(Fig. 5C). In hormone-treated cells,WT, T171A and S232A receptors
demonstrated declining transcriptional activity that was depen-
dent on increasing methionine concentrations whereas S224A and
S246A were mostly unaffected by methionine levels (Fig. 5C). The
mutation of S246A clearly shows that this receptor derivative is a
more potent activator of transcription than the wild type recep-
tor suggesting that the phosphorylation of this amino acid has
inhibitory effect on receptor function. Increased activity of this
mutant was observed in both the absence and the presence of
hormone.
4. Discussion
In this study we examined the phosphorylation of the gluco-
corticoid receptor (GR) expressed in yeast S. cerevisiae. Ectopically
expressed receptor is competent for transcriptional regulation and
signal transduction despite the fact that no endogenous glucocor-
ticoid receptor has been detected in yeast [5,13]. Orthophosphate
labeling in vivo and V8 protease digestion that yields simple and
clear phosphopeptide pattern indicated that GR phosphorylation
is similar in yeast and mammalian cells (Fig. 1). The obtained maps
were substantially simpler in all cases, than the phosphotryptic
maps we previously described [14], reﬂecting the fact that there
were fewer primary cleavage sites for this protease, aswell as fewer
partial products generated by incomplete digestion. Using this
method, we ﬁnd that the mutation of S246 into alanine increases
GR phosphorylation on S224 and S232 (Fig. 2). This conclusion was
supported by the use of synthetic nonradioactive phosphopeptides
that recapitulated in vivo peptide pattern. In addition, there were
no differences in solubility of these synthetic phosphopeptides
supporting the notion that interdependence of phosphorylation
sites is conserved in yeast and mammalian cells suggesting that
yeast homologues of cofactors [15,18] potentially involved in con-
ferring this interdependence are conserved in yeast. Substantial
body of evidence has indicated that phosphorylation is a very
important post-translational modiﬁcation regulating the function
of many transcription factors. As such phosphorylation has been
studied extensively in steroid receptors (SR) and the phosphory-
lated residues within GR, progesterone and oestrogen receptors
have been determined in human, mouse, rat, chicken and yeast
cells [2,16,17]. These residues are mainly localized within the N-
terminal transcriptional-activating domain of the receptor (AF1)
implying that phosphorylation is a potential regulator of GR tran-
scriptional activity. Overexpression of the wild type and the above
N. Popovic et al. / Steroids 75 (2010) 457–465 463
Fig. 5. Effect of glucocorticoid receptor phosphorylation analysed in the regulable expression system. (A) Western blot analysis of the expression levels of the WT and mutant
GR derivatives expressed from the p414 MET25 plasmid. (B) Quantiﬁcation of the WT and mutant GR protein levels. (C) Transcriptional activity of the wild type GR or its
d tration
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perivatives was measured using -galactosidase assay with the increasing concen
resented as mean± SEM (n=6) from six or more independent measurements. St
ormone are given as *p<0.05. Statistically signiﬁcant differences between sample
ormone in the presence of methionine (25–400M met), are given as #p<0.05.entioned mutant GR proteins in yeast indicated that differences
n the transcriptional potency of these derivatives were not statis-
ically signiﬁcant, although potential inhibitory trend of the MAPK
nd stimulatory tendency of the CDK targeted sites were observed,
ossibly due to GR overexpression masking the effects of GR phos-of methionine in the absence and presence of hormone as indicated. Results are
ally signiﬁcant differences between untreated samples and samples treated with
ed with hormone in the absence of methionine (met 0), and samples treated withphorylation (Fig. 4). In agreement with our results presented in
Fig. 4, it has been shown that themutationof somephosphorylation
sites ofmouseGRexpressed in yeast ormammalian cells havemod-
est or no effect on receptor transcriptional function when receptor
was constitutively overexpressed [26–28]. However, recent reports
4 eroids
h
a
p
c
t
g
l
d
r
c
m
e
w
t
S
l
d
T
l
P
r
t
d
t
l
s
G
p
b
h
T
G
p
u
b
c
t
p
t
u
e
v
h
d
d
s
m
o
n
o
s
s
b
r
p
t
c
t
A
f
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[64 N. Popovic et al. / St
ave described transient and target gene speciﬁc effects of kinase
ctivation on endogenous GR transcriptional activity [10,11].
The above mentioned difﬁculties in studying the effects of
hosphorylation on GR function justiﬁed the effort to develop a
ontrollable and genetically tractable system to further investigate
his important post-translationalmodiﬁcation. For this purposewe
enerated series of constructs carrying promoter which is regu-
ated by methionine concentration expressing wild type and GR
erivatives bearing mutations in four phosphorylation sites. Our
esults indicate that the concentration of the receptor is one of the
rucial factors determining its transcriptional activity and different
utants display varying degree of dosage dependency (Fig. 5). For
xample, S246A mutant shows increased activity compared to the
ild type receptor throughout the range of methionine concentra-
ions and its activity is largely independent on the receptor dosage.
224A mutant activity is mainly independent from the GR protein
evels. However, the wild type, T171A and S232A receptors display
ecreased activity with decreased levels of the receptor protein.
hese results suggest that there is a link between GR phosphory-
ation and its protein stability [8] as reported for other SRs [29].
erhaps phosphorylation state controls GR ubiquitination and/or
ecruitmentof componentsofproteasomeand thisprocess is linked
o GR transcriptional activity [29,30]. We have observed increased
egradation of the S246A derivative (Fig. 5A) indicating poten-
ial involvement of phosphorylation in control of the GR protein
evels, but further investigation is needed to conﬁrm this conclu-
ion. Phosphorylation of S246 by JNK has been shown to increase
R sumoylation and mixed SUMO and ubiquitin chains have been
roposed toplaya role in transcriptional regulationandprotein sta-
ility [10]. In fact, the link between proteasome and transcription
as been established for several other transcription factors [31].
ogether, our results support a model in which phosphorylation of
R at S246 compromises GR transcriptional activity by preventing
hosphorylation at S224 and S232 (Fig. 3 and [15]). Possible molec-
lar mechanisms include alternative protein–protein interactions
etween differentially phosphorylated GR and its transcriptional
ofactors. Similar mechanism has been described for the interac-
ion between CREB transcription factor and its coactivator protein
300/CBP [16,17,32,33,34]. Recent report by Chen et al. indicates
hat S211 (a human analogue of the rat S232) phosphorylation reg-
lates cofactor interaction in a target gene speciﬁc way and that
ffects of phosphorylation are dependent on the amount of acti-
ated receptor [35]. Although experimental approach described
ere is limited to a single target gene, it offers the advantage of
eveloping genetic screen for protein–protein interactions that are
ependent on the GR dosage and on the GR phosphorylation. We
peculate that GR protein levels may be important in the deter-
ination of the GR phosphorylation effects [8,27] which may be
f special importance in vivo under the conditions of low endoge-
ous hormone levels [36]. Differential interaction of the hyper-
r hypo-phosphorylated receptor with components of the protea-
ome might affect its half-life and ensure that GR activity and its
tability are regulated in coordinated fashion.
In conclusion, the simple system described in this report will
e useful in the investigation of the complex effects of phospho-
ylation by providing detailed insight in several aspects of the
hysiological role of phosphorylationof steroid receptors andother
ranscription factors and it is the initial step towards isolation of
ofactors which demonstrate differential interaction proﬁle with
he hyper versus the hypo-phosphorylated GR.cknowledgments
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